Readoutin 14d
Veradermics, Inc. — VDPHL01
Phase 3 primary completion: Safety and Efficacy of VDPHL01 in Males With AGA.
- Date
- Dec 2026
- Type
- Readout
- Indication
- Androgenetic Alopecia
Readoutin 14d
Phase 3 primary completion: Safety and Efficacy of VDPHL01 in Males With AGA.
The weekly brief is free. Pro adds reminders 7 days and 1 day before.